EUVIMEDEUVIMED entdecken
Crossref

Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States

Atsuyuki Watanabe iD, Hiroki A Ueyama, Yoshihisa Miyamoto iD, Hiroshi Gotanda iD, Tsuyoshi Kaneko iD, Azeem Latib iD, Dhaval Kolte iD, Suzanne J Baron iD, Eric Secemsky iD, Roger J Laham iD, Yusuke Tsugawa iD, Toshiki Kuno iD

Circulation: Cardiovascular Quality and Outcomes · 2025

DOI: 10.1161/circoutcomes.125.012134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2025. Verfasst von Atsuyuki Watanabe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY (A.W.). Hauptthemen laut MEDLINE: Cardiac Catheterization, Mitral Valve, Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The dissemination of novel procedures should attempt to strike a balance between access and procedure quality. This study aimed to evaluate the temporal trends and geographic dispersion of mitral transcatheter edge-to-edge repair (M-TEER) sites and to examine the associations of site volume and site-to-population density with patient outcomes. METHODS: We used the Medicare administrative databases in the United States to identify sites performing M-TEER in patients aged 65 to 99 years from 2017 to 2020 and examined the annualized volume and site-to-population density (per million beneficiaries in each corresponding hospital referral region). A hierarchical Cox regression analysis accounting for site-level clustering was performed to assess the association of site volume and density with 30-day and 1-year all-cause mortality. RESULTS: We identified 456 sites performing M-TEER in 16 810 patients (median [interquartile range] age, 81 [75–86] years; female, 47%). The case number of M-TEER increased by 54% from 3125 in 2017 to 4820 in 2020, while sites performing M-TEER increased by 71% from 252 in 2017 to 432 in 2020, corresponding to a decline in the median patient-to-site distances from 37.1 kilometers (interquartile range, 14.4–105.0) to 28.6 kilometers (interquartile range, 12.8–74.9). Higher site volume (every 10 cases/y) was associated with lower 30-day (adjusted hazard ratio, 0.94 [95% CI, 0.91–0.99]) and 1 year (adjusted hazard ratio, 0.98 [95% CI, 0.96–1.00]) mortality, while there was insufficient evidence to determine the association between higher site density (every 1 site/million-beneficiaries) and 30-day (adjusted hazard ratio, 1.00 [95% CI, 0.99–1.02]) and 1-year (adjusted hazard ratio, 1.00 [95% CI, 0.99–1.01]) mortality. CONCLUSIONS: Although sites performing M-TEER have been rapidly expanding, we did not find associations between higher regional site density and patient mortality. Continuous careful planning in disseminating M-TEER while ensuring adequate procedure volume per site may optimize patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationMitral ValveMitral Valve InsufficiencyHeart Valve Prosthesis ImplantationHealth Services AccessibilityPractice Patterns, Physicians'Healthcare DisparitiesHumansUnited StatesAgedFemaleMaleAged, 80 and overTreatment OutcomeTime FactorsDatabases, FactualMedicareRisk FactorsRisk AssessmentRetrospective Studies

Stichwörter der Autor:innen

heart failureinpatientpercutaneous coronary interventionpopulation densityregression analysis

Autor:innen und Institutionen

  • Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY (A.W.).
  • Division of Cardiology, Emory University School of Medicine, Atlanta, GA (H.A.U.).
  • Department of Real-world Evidence, Graduate School of Medicine, The University of Tokyo, Japan (Y.M.).
  • Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (H.G.).
  • Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO (T. Kaneko).
  • Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY (A.L.).

ORCID-Profile: Atsuyuki Watanabe, Yoshihisa Miyamoto, Hiroshi Gotanda, Tsuyoshi Kaneko, Azeem Latib, Dhaval Kolte, Suzanne J Baron, Eric Secemsky, Roger J Laham, Yusuke Tsugawa, Toshiki Kuno

Zitieren

APA

Watanabe, A., Ueyama, H. A., Miyamoto, Y., Gotanda, H., Kaneko, T., Latib, A., Kolte, D., Baron, S. J., Secemsky, E., Laham, R. J., Tsugawa, Y., & Kuno, T. (2025). Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.125.012134

Vancouver

Watanabe A, Ueyama HA, Miyamoto Y, Gotanda H, Kaneko T, Latib A, et al. Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States. Circulation: Cardiovascular Quality and Outcomes. 2025. doi:10.1161/circoutcomes.125.012134

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Atsuyuki and Ueyama, Hiroki A and Miyamoto, Yoshihisa and Gotanda, Hiroshi and Kaneko, Tsuyoshi and Latib, Azeem and Kolte, Dhaval and Baron, Suzanne J and Secemsky, Eric and Laham, Roger J and Tsugawa, Yusuke and Kuno, Toshiki},
  title = {Uptake, Geographic Access, and Outcomes of Transcatheter Mitral Valve Repair in the United States},
  journal = {Circulation: Cardiovascular Quality and Outcomes},
  year = {2025},
  doi = {10.1161/circoutcomes.125.012134}
}
Kostenlos starten →